Roquefort Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.34	0.54	2.32	0.9
Cash & Short-Term Investments	0.34	0.54	2.32	0.9
Cash Growth	-37.26%	-76.87%	158.19%	-
Accounts Receivable	-	-	-	0.02
Other Receivables	0.01	0.11	0.05	2.14
Receivables	0.01	0.11	0.05	2.15
Prepaid Expenses	0.01	0.05	0.06	0.03
Total Current Assets	0.36	0.69	2.42	3.08
Property, Plant & Equipment	0.04	0.05	-	-
Goodwill	0.28	0.28	0.28	0.28
Other Intangible Assets	5.06	5.06	5.06	1.2
Total Assets	5.75	6.09	7.77	4.56
Accounts Payable	0.02	0.14	0.07	0.04
Accrued Expenses	0.16	0.16	0.21	0.15
Short-Term Debt	0.4	-	-	-
Total Current Liabilities	0.58	0.31	0.28	0.2
Long-Term Deferred Tax Liabilities	0.28	0.28	0.28	0.28
Total Liabilities	0.86	0.59	0.56	0.48
Common Stock	1.36	1.29	1.29	0.72
Additional Paid-In Capital	4.62	4.4	4.4	3.46
Retained Earnings	-5.27	-4.29	-2.55	-0.91
Comprehensive Income & Other	4.18	4.1	4.06	0.82
Shareholders' Equity	4.89	5.5	7.21	4.08
Total Liabilities & Equity	5.75	6.09	7.77	4.56
Total Debt	0.4	-	-	-
Net Cash (Debt)	-0.06	0.54	2.32	0.9
Net Cash Growth	-	-76.87%	158.19%	-
Net Cash Per Share	-0.00	0.00	0.02	0.04
Filing Date Shares Outstanding	135.74	129.15	129.15	71.9
Total Common Shares Outstanding	135.74	129.15	129.15	71.9
Working Capital	-0.22	0.39	2.15	2.88
Book Value Per Share	0.04	0.04	0.06	0.06
Tangible Book Value	-0.45	0.16	1.86	2.6
Tangible Book Value Per Share	-0.00	0.00	0.01	0.04

Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.